HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relative activities of acyclovir and BW759 against Aujeszky's disease and equine rhinopneumonitis viruses.

Abstract
Compound BW759 (9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine) was shown to be about 230 times more active than acyclovir (9-[2-hydroxyethoxymethyl]guanine) (ACV) against Equid herpesvirus type 1 infection in Syrian hamsters and was more effective against Aujeszky's disease in mice. The therapeutic superiority of BW759 over ACV was greater than expected from quantitative inhibitory results in tissue culture with these viruses. When administered to hamsters at dose rates sufficient to prevent any Equid herpesvirus type 1-induced mortality (100 mg of ACV per kg per day; 3 mg of BW759 per kg per day), BW759 inhibited viral multiplication, as judged by histopathological observations, clinical chemistry, and liver virus concentrations, to a greater extent than ACV. Compound BW759 was particularly effective when administered via the oral route. The reasons for the superiority of BW759 over ACV remain to be elucidated.
AuthorsE A Rollinson, G White
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 24 Issue 2 Pg. 221-6 (Aug 1983) ISSN: 0066-4804 [Print] United States
PMID6314886 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Alkaline Phosphatase
  • Ganciclovir
  • Acyclovir
Topics
  • Acyclovir (analogs & derivatives, therapeutic use)
  • Alkaline Phosphatase (analysis)
  • Animals
  • Antiviral Agents (therapeutic use)
  • Body Weight (drug effects)
  • Cricetinae
  • Ganciclovir
  • Herpesviridae Infections (drug therapy)
  • Herpesvirus 1, Equid
  • Liver (pathology)
  • Male
  • Mesocricetus
  • Mice
  • Mice, Inbred Strains
  • Pseudorabies (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: